Copaxone
BNAC/GA/01
Approved small_molecule completed
Quick answer
Copaxone for Multiple Sclerosis is a Approved program (small_molecule) at Teva Pharma GmbH with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Multiple Sclerosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed